Portola Pharmaceuticals, Inc. Defined Contribution Plan, Cost
Portola Pharmaceuticals, Inc. reported Defined Contribution Plan, Cost of $1.70 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2020-02-28
- Portola Pharmaceuticals, Inc. defined contribution plan, cost for fiscal 2019 was $1.70M, a 30.77% increase from fiscal 2018.
- Portola Pharmaceuticals, Inc. defined contribution plan, cost for fiscal 2018 was $1.30M, a 44.44% increase from fiscal 2017.
- Portola Pharmaceuticals, Inc. defined contribution plan, cost for fiscal 2017 was $900.00K, a 12.50% increase from fiscal 2016.
- Portola Pharmaceuticals, Inc. defined contribution plan, cost for fiscal 2016 was $800.00K, a 52.38% increase from fiscal 2015.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2019-12-31 | $1.70M 10-K · filed 2020-02-28 | |
| 2018-12-31 | $1.30M 10-K · filed 2020-02-28 | |
| 2017-12-31 | $900.00K 10-K · filed 2020-02-28 | $910.00K 10-K · filed 2018-03-01 |
| 2016-12-31 | $800.00K 10-K · filed 2019-03-01 | $819.00K 10-K · filed 2017-03-01 |
| 2015-12-31 | $525.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $153.00K 10-K · filed 2017-03-01 | |
| 2013-12-31 | $59.00K 10-K · filed 2016-02-29 | |
| 2012-12-31 | $31.00K 10-K · filed 2015-03-02 | |
| 2011-12-31 | $35.00K 10-K · filed 2014-03-03 |